Vanguard Capital Management
MIRA icon

Vanguard Capital Management’s MIRA Pharmaceuticals MIRA Stock Holding History

Vanguard Capital Management’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712K Buy
751,801
+57,889
+8% +$58.5K ﹤0.01% 3653
2026
Q1 		$742K Buy
+693,912
New +$870K ﹤0.01% 3610

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Vanguard Capital Management's MIRA Position: Q2 2026 in Review

Vanguard Capital Management increased its MIRA Pharmaceuticals (MIRA) stake by 8.3% in Q2 2026, buying an estimated $58.5K and bringing the position to 751,801 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #3653.

Vanguard Capital Management first reported a position in MIRA in Q1 2026 and has held it in 2 quarters since. The position peaked at $742K in Q1 2026. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

  • Vanguard Capital Management held 751,801 shares of MIRA Pharmaceuticals worth $712K as of Q2 2026.
  • Vanguard Capital Management bought 57,889 MIRA Pharmaceuticals shares in Q2 2026, an estimated $58.5K.
  • MIRA Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3653 holding.
  • Vanguard Capital Management first reported a position in MIRA Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's MIRA Pharmaceuticals position peaked at $742K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.